INTRODUCTION

26
The n-3 long chain fatty acids (LCPUFA) eicosapentaenoic acid (EPA, 20:5 n-3) and 27 docosahexaenoic acid (DHA, 22:6 n-3) have a number of reported health benefits in humans, 28 in particular in relation to cardiovascular [1] and inflammatory [2, 3] conditions. This has led 29 to recommendations from health agencies world-wide to increase dietary intake of these fatty 30 acids [4] . EPA and DHA are mainly derived pre-formed through consumption of either fish 31 or fish-oil supplements. However, they can also be synthesised de novo through conversion 32 of the plant-derived short-chain n-3 PUFA precursor, alpha-linolenic acid (ALA, 18:3 n-3). It 33 has been suggested that increasing dietary intake of ALA could provide an alternative to fish 34 or fish-oil intake for increasing n-3 LCPUFA status in humans, although the efficiency of this 35 process in adult humans is generally low [5] .
37
The levels of n-6 PUFA also have the potential to impact on n-3 LCPUFA status. This is due 38 to the competition between n-6 and n-3 PUFA for both enzymatic conversion of the short-39 chain precursors, linoleic acid (LA, and ALA, to their respective long-chain 40 derivatives, and for incorporation into cell membranes [6] . LA competes with ALA for the 41 desaturase and elongase enzymes required for its conversion to EPA and DHA, and as a 42 result, high levels of LA in the background diet reduce the efficiency of endogenous 43 synthesis of n-3 LCPUFA from ALA [6] . In addition, since the incorporation of n-3
44
LCPUFA into the cellular membrane is required for them to mediate certain biological 45 effects, increased competition from n-6 PUFA can affect the relationship between n-3 PUFA 46 intake and tissue n-3 PUFA status [7, 8] . It has therefore been suggested that excessive 47 intakes of dietary n-6 PUFA may limit the ability of ALA and n-3 LCPUFA consumed in the 48 diet to increase n-3 LCPUFA status, and that reducing n-6 PUFA intake could potentially 49 improve n-3 LCPUFA status without a need to increase n-3 LCPUFA intake [8] . This has 50 4 particular significance given the substantial increases in n-6 PUFA intakes in Western 51 countries world-wide over the past century [9, 10] .
53
Animal studies have highlighted that levels of n-3 LCPUFA in tissues can be regulated by 54 simply altering the balance of LA and ALA in the diet and that a dose-response relationship 55 exists between dietary ALA intake and the n-3 LCPUFA content of blood and tissues [11] [12] [13] .
56
There is also evidence that reducing the LA content of infant formulas increases the 57 efficiency of cellular DHA incorporation in human infants [14] . However, there have been 58 comparatively few studies evaluating the effects of increasing dietary ALA and/or decreasing 59 n-6 PUFA intake on n-3 LCPUFA status in adult humans, and these results have yet to be 60 systematically evaluated.
62
This paper presents a review of human studies investigating the effect of altering dietary
63
ALA and LA intakes on n-3 LCPUFA status. In assessing these studies, we have identified a 64 number of common methodological issues, and therefore include a series of 65 recommendations to improve the quality of future studies in fatty acid nutrition in humans. were searched for relevant articles using the search terms "alpha linolenic acid" OR "a-71 linolenic acid" OR "ALA" or "linoleic acid" or "omega 6 fatty acid" OR "n-6 fatty acid" The dietary interventions in these studies were categorized based on the approach applied to 111 improve n-3 LCPUFA status, i.e. increasing intake of the short-chain n-3 PUFA, ALA, to 112 provide more substrate for conversion to n-3 LCPUFA, reducing intake of the short-chain n-6 113 PUFA, LA, to reduce competition for ALA conversion/n-3 LCPUFA cellular incorporation 114 or a combination of both. Alternative dietary approaches were placed in a fourth sub-115 category.
117
The characteristics of the sub-categories were:
118
(1) Increasing dietary intake ALA to between 1.1 and 6.3%E while maintaining dietary LA 119 intake in the normal range (4.3-7.3%E) (n=9). 
Intervention
132
The majority of trials in all categories used capsules, liquid oil or specially produced were conducted in free living individuals who were provided with fortified foods to add to 137 their normal diet and/or were advised on foods to consume and/or to avoid at home.
138
Individually designed diets which were kilojoule and nutrient controlled according to energy 139 requirements were used in the remaining 5 studies [16, [19] [20] [21] [22] .
141
Flaxseed/linseed oil (LA, 16%; ALA, 57% of total fatty acids) was the oil most commonly 142 used to increase dietary ALA, while sunflower (LA, 64% of total fatty acids) and canola (LA, 143 20%; ALA, 10% of total fatty acids) oils were used to increase dietary n-6 in the majority of 144 studies. These oils were either provided in the form of capsules or added to foods to modify 145 the dietary fat profile. One study used macadamia oil (LA, 1-3%; ALA, 1-2% of total fatty 146 acids) in the low LA dietary intervention [18] . Studies which aimed to reduce n-6 PUFA 147 intake that did not utilize individually prescribed diets provided specific instructions to 
150
Thirteen studies [16, [18] [19] [20] [21] [23] [24] [25] [26] [27] [28] [29] [30] allowed fish during the high ALA/low LA dietary 151 intervention, while 7 studies excluded fish [22, [31] [32] [33] [34] [35] [36] . Two studies excluded all meat sources 152 from the diet throughout the trial [33, 37] . 
Method of recording dietary intake
154
A number of methods were used to assess dietary intake in these studies. The use of a 155 weighed food diary was reported in 7 of the 20 trials [18, 22, 23, [30] [31] [32] [33] . However, of these, 156 diaries were kept only for one week during the intervention period in three studies [22, 31, 157 32] and in one study the length of time the diaries were kept was not reported [30] . Six 158 studies stated that dietary intake was assessed using food diaries/records, however no details 159 of the methodology were provided, and it was unclear whether or not the foods in these 160 records were weighed [25, 26, 29, [34] [35] [36] The fact that, of the 7 studies which decreased LA intake without a concomitant increase in status following the low LA diet, however it is difficult to determine the extent to which this 255 was due to the reduction in LA intake, since the authors also reported that fish intake 256 increased 2-fold during the intervention period compared to baseline. This latter example 257 highlights the importance of ensuring that the intake of fatty acids other than those which are 258 the subject of study are maintained at a constant level during the intervention period.
259
The results of the human studies conducted to date suggest that the most effective strategy for 260 increasing n-3 LCPUFA was a combined approach involving both an increase in ALA and 261 decrease in LA intake, with 6 of the 7 studies which took this approach reporting significant 262 increases in EPA status at the end of the intervention. The one study that was not successful 263 with this intervention was conducted on a small group of males (n=16) [19] , and it is possible 264 that the failure to detect an effect was due to the lower efficiency of conversion of ALA to
265
EPA in males compared to females [38] . In addition, the study involved a cross-over design 266 in which the control and low LA/high ALA diets were fed to the same individuals over 2 267 separate 56-day periods, but failed to include a wash-out period between the diets. This to have impacted on the response of the individual to the subsequent diet.
270
While the combination of reduced LA and increased ALA intake appears to be effective at 271 increasing EPA, the current evidence suggests that its efficacy in increasing DHA status may that appropriate run-in periods are applied prior to the intervention where this is not the case.
311
The majority of studies included in this review included small numbers of participants, and 312 no study provided any justification for the sample size used or indication if they provided 313 sufficient statistical power to limit type 1 errors. In addition, the majority of these studies 314 included both male and female participants, and did not assess the results separately by sex.
315
This is significant given the well-established differences in fatty acid metabolism between 316 males and females, in particular the ~2. e.g. where fish will be excluded.
337
In conclusion, while the current data support the suggestion that n-3 LCPUFA status in 338 humans can be increased in the absence of increased n-3 LCPUFA intake, there is a need for 339 well-controlled and adequately powered studies in males and females in order to evaluate 340 whether these diets could be a viable alternative to n-3 LCPUFA supplementation for 341 achieving improvements in human health. 
